Federal Supply Schedule 36F79719D0108

Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., holds a $225,000 Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the General Services Administration (GSA). Under this multiple award IDIQ contract, Amicus Therapeutics US, LLC has been awarded various delivery orders by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to provide the pharmaceutical product Galafold (migalastat) to support healthcare services for veterans. The delivery orders, valued from approximately $18,000 to $222,000, are primarily firm fixed price and do not utilize any set-aside designations. Galafold is an FDA-approved enzyme replacement therapy used to treat Fabry disease, a rare genetic disorder. The delivery orders cover pharmaceutical supply to VHA facilities and service networks in regions such as Philadelphia, Pennsylvania, including VISN 5, VISN 7, VISN 9, and VISN 21. This contracting vehicle enables the VA to procure needed specialty medications to fulfill its mission of providing comprehensive healthcare to the veteran population.